BFC Planning’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
BFC Planning's PTCT Position: Q3 2026 in Review
BFC Planning held its PTC Therapeutics (PTCT) position steady in Q3 2026 at 178 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.
BFC Planning first reported a position in PTCT in Q4 2024 and has held it in 6 quarters since. The position peaked at $28.5K in Q4 2025. 281 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- BFC Planning held 178 shares of PTC Therapeutics worth $11.5K as of Q3 2026.
- BFC Planning left its PTC Therapeutics share count unchanged in Q3 2026.
- PTC Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2308 holding.
- BFC Planning first reported a position in PTC Therapeutics in Q4 2024 and has held it in 6 quarters since.
- BFC Planning's PTC Therapeutics position peaked at $28.5K in Q4 2025.
- 281 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.